Grant: Discovery Grants Program - Individual
Ryerson University
$25,000.00
Particle Coating In Two-Phase Microfluidic Co-Flows
FY 2018-19
Summary
Cell transplantation therapies have shown great promise in treating diseases such as type I diabetes. However, the patients in all of the successful clinical treatments so far have been required to use immunosuppressive drugs. These drugs are often harmful to organs such as kidneys. Yet, without immunosuppression, the transplanted cells may be quickly destroyed by the patient's immune system.*Our laboratory is pursuing a new particle coating technology that will enable cell transplantation treatments without immunosuppression. We are developing the capability to coat individual particles, such as the cells being used in the treatment of type I diabetes, with a bio-compatible polymer membrane that protects the cells from the immune system and facilitates the transport of nutrients across the membrane.*We use a microfluidics platform--a system of microchannels where viscosity and surface tension dominate the physics of fluid flow--to develop our technology, and leverage our expertise in fluid mechanics and electromagnetism to control the coating process. Our approach includes both experimental observation of the coated single cells and mathematical modeling of the coating flow.*Most of all, we expect that our coating technology will greatly improve the viability of transplanted cells, which can positively impact the Canadian health care and biotechnology industries. We also anticipate significant interest from the global fluid mechanics community in our coating flow studies. Finally, through participation in this research program, our highly qualified personnel (HQP) will develop interdisciplinary skills in fields as diverse as engineering, medicine, and mathematics. These HQP will populate Canadian industry and apply our microscale coating technique to solve a variety of problems. *
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
435514-2013
Name nom
Tsai, Scott
Department département
Mechanical and Industrial Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2013
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1512
Committee name en
Mechanical Engineering
Committee name fr
Génie mécanique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2100
Research subject group en
Mechanical engineering
Research subject group fr
Génie mécanique
Research subject en
Mechanical engineering
Research subject fr
Génie mécanique
Partie
6
Nb partie
6
Application title
Particle Coating In Two-Phase Microfluidic Co-Flows
Keyword
NSERC
Application summary
Cell transplantation therapies have shown great promise in treating diseases such as type I diabetes. However, the patients in all of the successful clinical treatments so far have been required to use immunosuppressive drugs. These drugs are often harmful to organs such as kidneys. Yet, without immunosuppression, the transplanted cells may be quickly destroyed by the patient's immune system.*Our laboratory is pursuing a new particle coating technology that will enable cell transplantation treatments without immunosuppression. We are developing the capability to coat individual particles, such as the cells being used in the treatment of type I diabetes, with a bio-compatible polymer membrane that protects the cells from the immune system and facilitates the transport of nutrients across the membrane.*We use a microfluidics platform--a system of microchannels where viscosity and surface tension dominate the physics of fluid flow--to develop our technology, and leverage our expertise in fluid mechanics and electromagnetism to control the coating process. Our approach includes both experimental observation of the coated single cells and mathematical modeling of the coating flow.*Most of all, we expect that our coating technology will greatly improve the viability of transplanted cells, which can positively impact the Canadian health care and biotechnology industries. We also anticipate significant interest from the global fluid mechanics community in our coating flow studies. Finally, through participation in this research program, our highly qualified personnel (HQP) will develop interdisciplinary skills in fields as diverse as engineering, medicine, and mathematics. These HQP will populate Canadian industry and apply our microscale coating technique to solve a variety of problems. *